Results 201 to 210 of about 239,667 (277)

Bridging the gap in sleep health: a study of obstructive sleep apnoea (OSA) in First Nations Australians residing in South East Queensland

open access: yesInternal Medicine Journal, Volume 56, Issue 4, Page 701-705, April 2026.
Abstract Obstructive sleep apnoea (OSA) is common in Australia but underexamined among First Nations peoples. We conducted a retrospective cross‐sectional analysis of 1563 adult sleep studies in South East Queensland (2022–2023). Thirty‐eight participants (2.4%) identified as First Nations, of whom 74% had OSA.
Stephanie Hadikusumo   +9 more
wiley   +1 more source

The Neuroplastic Narrative and Neuro‐Ecological Diversity: Non‐Pathologizing Biological Foundations for Trauma‐Informed Medical and Mental Health Nursing

open access: yesInternational Journal of Mental Health Nursing, Volume 35, Issue 2, April 2026.
ABSTRACT Following the Adverse Childhood Experiences study (1998), a wealth of similar studies has strongly associated experiences of trauma and adversity in childhood with increased risk of poor physical and mental health and undesirable social outcomes in adulthood.
Haley Peckham, Bridget Hamilton
wiley   +1 more source

Adjunctive Systemic Amoxicillin and Metronidazole Following Surgical Peri‐Implantitis Treatment: A Single‐Blind Randomised Controlled Trial With a 1‐Year Follow‐Up

open access: yesJournal of Clinical Periodontology, Volume 53, Issue 4, Page 550-561, April 2026.
ABSTRACT Aim To analyse the effect of systemic amoxicillin and metronidazole on surgical peri‐implantitis treatment with a follow‐up period of 1 year. Materials and Methods Fifty‐nine patients were randomly assigned to receive peri‐implantitis surgery supplemented with (29 patients; test) or without (30 patients; control) systemic amoxicillin and ...
Jarno Hakkers   +4 more
wiley   +1 more source

<i>In vitro</i> physicochemical characterization of nephropathogenic strain of infectious bronchitis virus isolated from poultry. [PDF]

open access: yesVet Res Forum
Saaed K   +10 more
europepmc   +1 more source

Efficacy and safety of ME3183, an oral phosphodiesterase 4 inhibitor, in patients with plaque psoriasis

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 4, Page 610-616, April 2026.
We assessed four different doses of ME3183, a novel phosphodiesterase 4 inhibitor, and placebo in 132 patients with moderate to severe plaque psoriasis. At Week 16, more patients receiving ME3183 achieved ≥75% reduction in baseline Psoriasis Area and Severity Index scores than those receiving placebo, with no new safety concerns.
Kim A. Papp   +5 more
wiley   +1 more source

Correction: Autologous P63+ lung progenitor cell transplantation in idiopathic pulmonary fibrosis: a phase 1 clinical trial.

open access: yesElife
Zhang S   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy